Fisher & Paykel Healthcare Corporation Limited (ASX: FPH)

FPH Statistics

Total Valuation

Fisher & Paykel Healthcare Corporation has a market cap or net worth of AUD 19.26 billion. The enterprise value is 19.36 billion.

Market Cap	19.26B
Enterprise Value	19.36B

Important Dates

The next estimated earnings date is Thursday, November 21, 2024.

Earnings Date	Nov 21, 2024
Ex-Dividend Date	Jun 26, 2024

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.78%
Shares Change (QoQ)	+0.56%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	583.82M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/FCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 46.36, with an EV/FCF ratio of 187.01.

EV / Earnings	159.08
EV / Sales	12.30
EV / EBITDA	46.36
EV / EBIT	60.67
EV / FCF	187.01

Financial Position

The company has a current ratio of 1.83, with a Debt / Equity ratio of 0.11.

Current Ratio	1.83
Quick Ratio	0.90
Debt / Equity	0.11
Debt / EBITDA	0.41
Debt / FCF	1.68
Interest Coverage	19.42

Financial Efficiency

Return on equity (ROE) is 7.55% and return on invested capital (ROIC) is 11.48%.

Return on Equity (ROE)	7.55%
Return on Assets (ROA)	9.85%
Return on Capital (ROIC)	11.48%
Revenue Per Employee	228,280
Profits Per Employee	17,369
Employee Count	7,031
Asset Turnover	0.78
Inventory Turnover	2.04

Taxes

In the past 12 months, Fisher & Paykel Healthcare Corporation has paid 92.78 million in taxes.

Income Tax	92.78M
Effective Tax Rate	43.74%

Stock Price Statistics

The stock price has increased by +59.94% in the last 52 weeks. The beta is 0.42, so Fisher & Paykel Healthcare Corporation's price volatility has been lower than the market average.

Beta (5Y)	0.42
52-Week Price Change	+59.94%
50-Day Moving Average	33.40
200-Day Moving Average	28.22
Relative Strength Index (RSI)	51.20
Average Volume (20 Days)	520,716

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Fisher & Paykel Healthcare Corporation had revenue of AUD 1.60 billion and earned 121.67 million in profits. Earnings per share was 0.21.

Revenue	1.60B
Gross Profit	958.29M
Operating Income	324.26M
Pretax Income	216.27M
Net Income	121.67M
EBITDA	408.13M
EBIT	324.26M
Earnings Per Share (EPS)	0.21

Balance Sheet

The company has 75.24 million in cash and 173.51 million in debt, giving a net cash position of -98.27 million.

Cash & Cash Equivalents	75.24M
Total Debt	173.51M
Net Cash	-98.27M
Net Cash Per Share	n/a
Equity (Book Value)	1.61B
Book Value Per Share	2.77
Working Capital	293.52M

Cash Flow

In the last 12 months, operating cash flow was 394.18 million and capital expenditures -290.68 million, giving a free cash flow of 103.50 million.

Operating Cash Flow	394.18M
Capital Expenditures	-290.68M
Free Cash Flow	103.50M
FCF Per Share	n/a

Margins

Gross margin is 59.93%, with operating and profit margins of 20.28% and 7.61%.

Gross Margin	59.93%
Operating Margin	20.28%
Pretax Margin	13.52%
Profit Margin	7.61%
EBITDA Margin	25.52%
EBIT Margin	20.28%
FCF Margin	6.47%

Dividends & Yields

Fisher & Paykel Healthcare Corporation does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	1.78%
Years of Dividend Growth	11
Payout Ratio	89.97%
Buyback Yield	-0.78%
Shareholder Yield	-0.78%
Earnings Yield	n/a
FCF Yield	n/a

Stock Splits

The last stock split was on September 27, 2004. It was a forward split with a ratio of 5.

Last Split Date	Sep 27, 2004
Split Type	Forward
Split Ratio	5

Scores

Fisher & Paykel Healthcare Corporation has an Altman Z-Score of 18.04 and a Piotroski F-Score of 3.

Altman Z-Score	18.04
Piotroski F-Score	3